Search Results

Containing any of the words

Only of the type

Treprostinil Risk Minimization Activity - New

Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies Drug Clinical Trial

SFDA Rejects AI-Powered Diabetes Prediction Device for Failing Safety and Efficacy Standards News

Workshop : “Pricing of Pharmaceutical Products” News

Amargine Risk Minimization Activity - New

Recalled all batches for some products produced by Achievement Scope Company for Industry Drugs Circulars and withdrawal

SFDA Leads Digital Transformation in Drug and Cosmetic Safety Regulation News

SFDA Approves the Registration of “Pemazyre” for the Treatment of Bile Duct Cancer in Adults News

Beyond Regulation: Technological Advancements in Pharmaceutical Oversight Scientific Magazines and articles

Vasopressin New SFDA Drug Approvals